If you made any changes in Pure, your changes will be visible here soon.

Research Output 1978 2019

Filter
Review article
2019

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., Feb 14 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Epidemiology
Neoplasms
End Stage Liver Disease
Cholangiocarcinoma

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Pruritus
Fatigue
Fibrosis
2018
8 Citations (Scopus)

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

Zakharia, K., Tabibian, A., Lindor, K. & Tabibian, J. H., Mar 1 2018, In : Liver International. 38, 3, p. 399-411 13 p.

Research output: Contribution to journalReview article

Liver Diseases
Quality of Life
Pregnancy
Sclerosing Cholangitis
Cholangitis
48 Citations (Scopus)

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Chalasani, N. P., Anstee, Q. M. & 4 others, Kowdley, K. V., George, J., Goodman, Z. D. & Lindor, K., Jul 1 2018, In : Hepatology. 68, 1, p. 361-371 11 p.

Research output: Contribution to journalReview article

Fatty Liver
Fibrosis
Therapeutics
Non-alcoholic Fatty Liver Disease
Clinical Trials
5 Citations (Scopus)

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Ponsioen, C. Y., Lindor, K., Mehta, R. & Dimick-Santos, L., Sep 1 2018, In : Hepatology. 68, 3, p. 1174-1188 15 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Clinical Trials
Gastroenterology
Rare Diseases
Natural History
50 Citations (Scopus)

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Younossi, Z. M., Loomba, R., Anstee, Q. M., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Goodman, Z. D. & 4 others, Chalasani, N. P., Kowdley, K. V., George, J. & Lindor, K., Jul 1 2018, In : Hepatology. 68, 1, p. 349-360 12 p.

Research output: Contribution to journalReview article

Fibrosis
Elasticity Imaging Techniques
Liver Cirrhosis
Liver
Non-alcoholic Fatty Liver Disease

Emerging therapeutic targets for primary sclerosing cholangitis

Kalani, A., Tabibian, J. H. & Lindor, K., Jul 3 2018, In : Expert Opinion on Orphan Drugs. 6, 7, p. 393-401 9 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Therapeutics
Liver Diseases
End Stage Liver Disease
Liver Transplantation

Primary sclerosing cholangitis in children versus adults: lessons for the clinic

Adike, A., Carey, E. J. & Lindor, K., Oct 3 2018, In : Expert Review of Gastroenterology and Hepatology. 12, 10, p. 1025-1032 8 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Pediatrics
Liver Diseases
Literature
Inflammatory Bowel Diseases
14 Citations (Scopus)

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis

Damman, J. L., Rodriguez, E. A., Ali, A. H., Buness, C. W., Cox, K. L., Carey, E. J. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 7, p. 886-895 10 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Vancomycin
Inflammatory Bowel Diseases
Therapeutics
Anti-Bacterial Agents
2017
3 Citations (Scopus)

Emerging treatments for primary sclerosing cholangitis

Rodriguez, E. A., Carey, E. J. & Lindor, K., May 4 2017, In : Expert Review of Gastroenterology and Hepatology. 11, 5, p. 451-459 9 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Therapeutics
End Stage Liver Disease
Cholangiocarcinoma
Inflammatory Bowel Diseases
2 Citations (Scopus)

Investigational drugs in phase II clinical trials for primary biliary cholangitis

Silveira, M. G. & Lindor, K., Oct 3 2017, In : Expert Opinion on Investigational Drugs. 26, 10, p. 1115-1121 7 p.

Research output: Contribution to journalReview article

Investigational Drugs
Phase II Clinical Trials
Cholangitis
Ursodeoxycholic Acid
Fibrosis
2016
10 Citations (Scopus)

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Steatorrhea
Ursodeoxycholic Acid
Cholangiocarcinoma
1 Citation (Scopus)

Novel treatments in primary sclerosing cholangitis

Ali, A. H. & Lindor, K., Nov 1 2016, In : Clinical Liver Disease. 8, 5, p. 132-135 4 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
17 Citations (Scopus)

Obeticholic acid for the treatment of primary biliary cholangitis

Ali, A. H. & Lindor, K., Sep 1 2016, In : Expert Opinion on Pharmacotherapy. 17, 13, p. 1809-1815 7 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Therapeutics
Alkaline Phosphatase
6-ethylchenodeoxycholic acid

Targets and investigative treatments for primary biliary cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Oct 2 2016, In : Expert Opinion on Orphan Drugs. 4, 10, p. 1011-1020 10 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Therapeutics
Phase III Clinical Trials
Phase II Clinical Trials
2015
104 Citations (Scopus)

Recent advances in the development of farnesoid X receptor agonists

Ali, A. H., Carey, E. J. & Lindor, K., Jan 1 2015, In : Annals of Translational Medicine. 3, 1, 5.

Research output: Contribution to journalReview article

Bile Acids and Salts
Chenodeoxycholic Acid
Insulin Resistance
Biliary Liver Cirrhosis
Wounds and Injuries